CVE-2013-7277

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in Andy's PHP Knowledgebase (Aphpkb) before 0.95.8 allow remote attackers to inject arbitrary web script or HTML via the (1) HTTP Referer header to saa.php, (2) username parameter to login.php, or (3) keyword_list parameter to keysearch.php.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.21%
Vendor Advisory blogspot.dk Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/64550 vdb entry
http://osvdb.org/101492 vdb entry
https://www.netsparker.com/critical-xss-vulnerabilities-andy-php-knowledgebase
http://sourceforge.net/p/aphpkb/code/91 patch exploit
http://aphpkb.blogspot.dk/2013/12/release-of-aphpkb-0958.html patch vendor advisory
http://osvdb.org/101467 vdb entry patch
http://osvdb.org/101491 vdb entry
http://secunia.com/advisories/56228 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2013-7277?
CVE-2013-7277 has been scored as a medium severity vulnerability.
How to fix CVE-2013-7277?
To fix CVE-2013-7277, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2013-7277 being actively exploited in the wild?
It is possible that CVE-2013-7277 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.